Literature DB >> 31401304

Pyruvate kinase M2: A simple molecule with complex functions.

Mohammed Alquraishi1, Dexter L Puckett1, Dina S Alani1, Amal S Humidat1, Victoria D Frankel1, Dallas R Donohoe1, Jay Whelan1, Ahmed Bettaieb2.   

Abstract

Pyruvate kinase M2 is a critical enzyme that regulates cell metabolism and growth under different physiological conditions. In its metabolic role, pyruvate kinase M2 catalyzes the last glycolytic step which converts phosphoenolpyruvate to pyruvate with the generation of ATP. Beyond this metabolic role in glycolysis, PKM2 regulates gene expression in the nucleus, phosphorylates several essential proteins that regulate major cell signaling pathways, and contribute to the redox homeostasis of cancer cells. The expression of PKM2 has been demonstrated to be significantly elevated in several types of cancer, and the overall inflammatory response. The unusual pattern of PKM2 expression inspired scientists to investigate the unrevealed functions of PKM2 and the therapeutic potential of targeting PKM2 in cancer and other disorders. Therefore, the purpose of this review is to discuss the mechanistic and therapeutic potential of targeting PKM2 with the focus on cancer metabolism, redox homeostasis, inflammation, and metabolic disorders. This review highlights and provides insight into the metabolic and non-metabolic functions of PKM2 and its relevant association with health and disease.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer; Glycolysis; Inflammation; Metabolic diseases; Oxidants; Pyruvate kinase M2; Redox homeostasis; Warburg effect

Mesh:

Substances:

Year:  2019        PMID: 31401304      PMCID: PMC6848794          DOI: 10.1016/j.freeradbiomed.2019.08.007

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  203 in total

1.  Identification of noninvasive biomarkers for nephrotoxicity using HK-2 human kidney epithelial cells.

Authors:  Sun Young Kim; So-Jung Sohn; A Jin Won; Hyung Sik Kim; Aree Moon
Journal:  Toxicol Sci       Date:  2014-06-30       Impact factor: 4.849

2.  Identification of small molecule inhibitors of pyruvate kinase M2.

Authors:  Matthew G Vander Heiden; Heather R Christofk; Eli Schuman; Alexander O Subtelny; Hadar Sharfi; Edward E Harlow; Jun Xian; Lewis C Cantley
Journal:  Biochem Pharmacol       Date:  2009-12-11       Impact factor: 5.858

3.  Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth.

Authors:  Taro Hitosugi; Sumin Kang; Matthew G Vander Heiden; Tae-Wook Chung; Shannon Elf; Katherine Lythgoe; Shaozhong Dong; Sagar Lonial; Xu Wang; Georgia Z Chen; Jianxin Xie; Ting-Lei Gu; Roberto D Polakiewicz; Johannes L Roesel; Titus J Boggon; Fadlo R Khuri; D Gary Gilliland; Lewis C Cantley; Jonathan Kaufman; Jing Chen
Journal:  Sci Signal       Date:  2009-11-17       Impact factor: 8.192

4.  Protein tyrosine phosphatase 1B regulates pyruvate kinase M2 tyrosine phosphorylation.

Authors:  Ahmed Bettaieb; Jesse Bakke; Naoto Nagata; Kosuke Matsuo; Yannan Xi; Siming Liu; Daniel AbouBechara; Ramzi Melhem; Kimber Stanhope; Bethany Cummings; James Graham; Andrew Bremer; Sheng Zhang; Costas A Lyssiotis; Zhong-Yin Zhang; Lewis C Cantley; Peter J Havel; Fawaz G Haj
Journal:  J Biol Chem       Date:  2013-05-02       Impact factor: 5.157

5.  PKM2 Thr454 phosphorylation increases its nuclear translocation and promotes xenograft tumor growth in A549 human lung cancer cells.

Authors:  Zhenhai Yu; Liangqian Huang; Pengyun Qiao; Aifang Jiang; Li Wang; Tingting Yang; Shengjian Tang; Wei Zhang; Chune Ren
Journal:  Biochem Biophys Res Commun       Date:  2016-04-01       Impact factor: 3.575

6.  AMP-activated protein kinase activity is required for vanadate-induced hypoxia-inducible factor 1alpha expression in DU145 cells.

Authors:  Jin-Taek Hwang; Minyoung Lee; Seung-Nam Jung; Hye-Jeong Lee; Insug Kang; Sung-Soo Kim; Joohun Ha
Journal:  Carcinogenesis       Date:  2004-08-05       Impact factor: 4.944

7.  Reactive oxygen species: role in the development of cancer and various chronic conditions.

Authors:  Gulam Waris; Haseeb Ahsan
Journal:  J Carcinog       Date:  2006-05-11

8.  Shikonin induces apoptosis in the human gastric cancer cells HGC-27 through mitochondria-mediated pathway.

Authors:  Yue Hou; Jinghua Xu; Xia Liu; Xichun Xia; Ning Li; Xiuli Bi
Journal:  Pharmacogn Mag       Date:  2015 Apr-Jun       Impact factor: 1.085

9.  Pyruvate Kinase M2: A Novel Biomarker for the Early Detection of Acute Kidney Injury.

Authors:  Ji Hyun Cheon; Sun Young Kim; Ji Yeon Son; Ye Rim Kang; Ji Hye An; Ji Hoon Kwon; Ho Sub Song; Aree Moon; Byung Mu Lee; Hyung Sik Kim
Journal:  Toxicol Res       Date:  2016-01-31

10.  Pyruvate kinase M2 deregulation enhances the metastatic potential of tongue squamous cell carcinoma.

Authors:  Wei Wang; Qianting He; Jingjing Sun; Zhonghua Liu; Luodan Zhao; Zhiyuan Lu; Xiaofeng Zhou; Anxun Wang
Journal:  Oncotarget       Date:  2017-07-17
View more
  24 in total

1.  Role of pyruvate kinase M2 in oxidized LDL-induced macrophage foam cell formation and inflammation.

Authors:  Amit Kumar; Priya Gupta; Minakshi Rana; Tulika Chandra; Madhu Dikshit; Manoj Kumar Barthwal
Journal:  J Lipid Res       Date:  2020-01-27       Impact factor: 5.922

Review 2.  Immunometabolism in the development of rheumatoid arthritis.

Authors:  Cornelia M Weyand; Jörg J Goronzy
Journal:  Immunol Rev       Date:  2020-01-27       Impact factor: 12.988

Review 3.  The Role of PKM2 in Metabolic Reprogramming: Insights into the Regulatory Roles of Non-Coding RNAs.

Authors:  Dexter L Puckett; Mohammed Alquraishi; Winyoo Chowanadisai; Ahmed Bettaieb
Journal:  Int J Mol Sci       Date:  2021-01-25       Impact factor: 5.923

4.  PKM2 Is Overexpressed in Glioma Tissues, and Its Inhibition Highly Increases Late Apoptosis in U87MG Cells With Low-density Specificity.

Authors:  Jae Hyeon Park; Jin-Sol Lee; Yunmoon Oh; Ji Sun Lee; Hae Eun Park; Haeun Lee; Yeon Su Park; So Young Kyung; Hyung Sik Kim; Sungpil Yoon
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

5.  Combination Treatment Using Pyruvate Kinase M2 Inhibitors for the Sensitization of High Density Triple-negative Breast Cancer Cells.

Authors:  Ji Sun Lee; Yunmoon Oh; Jin-Sol Lee; Jae Hyeon Park; Joo-Kyung Shin; Joo-Hee Han; Hyung Sik Kim; Sungpil Yoon
Journal:  In Vivo       Date:  2022 Sep-Oct       Impact factor: 2.406

Review 6.  Glycolysis in Innate Immune Cells Contributes to Autoimmunity.

Authors:  Yue Xu; Yongkang Chen; Xuan Zhang; Jie Ma; Yudong Liu; Liyan Cui; Fang Wang
Journal:  Front Immunol       Date:  2022-07-01       Impact factor: 8.786

7.  Podocyte specific deletion of PKM2 ameliorates LPS-induced podocyte injury through beta-catenin.

Authors:  Mohammed Alquraishi; Samah Chahed; Dina Alani; Dexter L Puckett; Presley D Dowker; Katelin Hubbard; Yi Zhao; Ji Yeon Kim; Laurentia Nodit; Huma Fatima; Dallas Donohoe; Brynn Voy; Winyoo Chowanadisai; Ahmed Bettaieb
Journal:  Cell Commun Signal       Date:  2022-05-30       Impact factor: 7.525

8.  HMGCR inhibition stabilizes the glycolytic enzyme PKM2 to support the growth of renal cell carcinoma.

Authors:  Jiajun Huang; Xiaoyu Zhao; Xiang Li; Jiwei Peng; Weihao Yang; Shengli Mi
Journal:  PLoS Biol       Date:  2021-04-27       Impact factor: 8.029

9.  Plasma Pyruvate Kinase M2 as a marker of vascular inflammation in giant cell arteritis.

Authors:  Idil Esen; William F Jiemy; Yannick van Sleen; Johan Bijzet; Daniel M de Jong; Pieter H Nienhuis; Riemer H J A Slart; Peter Heeringa; Annemieke M H Boots; Elisabeth Brouwer
Journal:  Rheumatology (Oxford)       Date:  2022-07-06       Impact factor: 7.046

Review 10.  Tumor pyruvate kinase M2 modulators: a comprehensive account of activators and inhibitors as anticancer agents.

Authors:  Bhagyashri Rathod; Shivam Chak; Sagarkumar Patel; Amit Shard
Journal:  RSC Med Chem       Date:  2021-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.